Gene · 79718
TBL1XR1: TBL1X/Y related 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TBL1XR1: TBL1X/Y related 1. Genes, record 79718. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/79718
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BZK7 | F-box-like/WD repeat-containing protein TBL1XR1 | 514 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents37
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 2276 | Q9BZK7 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1848 | Q9BZK7 | Espacenet |
| JP 2025532979 A | 2025-10-03 | 184 | Q9BZK7 | Espacenet |
| EP 4593850 A2 | 2025-08-06 | 184 | Q9BZK7 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1848 | Q9BZK7 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2276 | Q9BZK7 | Espacenet |
| US 12295971 B2 | 2025-05-13 | 184 | Q9BZK7 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 7611 | Q9BZK7 | Espacenet |
| US 11564998 B2 | 2023-01-31 | 8197 | Q9BZK7 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 89961 | Q9BZK7 | Espacenet |
1 to 10 of 37
See all 37 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,294
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TBL1XR1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 11 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 7 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 5 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 5 | 2025 |
| ZIASC000550 | Lymphoma Disease Discovery and Definition | 5 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 4 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 4 | 2025 |
| R01MH101221 | Rare Mutations and Autism Spectrum Disorders | 4 | 2025 |
1 to 10 of 1,294Source NIH's project files
See all 1,294 nih grantsPapers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulated expression of the EMX2OS/miR-34c-5p/TBL1XR1 regulatory axis: a novel signature for severe community-acquired pneumonia in children. | BMC Pediatr | 2026 | 42750020 | PubTator, text mining | PubMed |
| Nodal marginal zone lymphoma: genetic analysis and the differential diagnosis from other small B-cell lymphomas. | Blood Adv | 2026 | 42721462 | PubTator, text mining | PubMed |
| Expanding the TBL1XR1 Disease Spectrum: Generalized Dystonia Associated with a New Genetic Variant. | Tremor Other Hyperkinet Mov (N Y) | 2026 | 42699641 | PubTator, text mining | PubMed |
| A genome-wide map of the genetic network in monocytes that regulates type I interferon induction by the cGAS-STING pathway. | Sci Signal | 2026 | 42611972 | PubTator, text mining | PubMed |
| Erratum: [Corrigendum] TBL1XR1 as a potential therapeutic target that promotes epithelial-mesenchymal transition in lung squamous cell carcinoma. | Exp Ther Med | 2026 | 42577676 | PubTator, text mining | PubMed |
| Molecular Feasibility of Gene Sequencing on Lymph Node Fine-Needle Cytology Samples of Non-Hodgkin Lymphoma. | Int J Mol Sci | 2026 | 42450228 | PubTator, text mining | PubMed |
| TBL1XR1 mutations promoted tumor progression in diffuse large B-cell lymphoma through impairing nature killer cytotoxicity via the MYC-CD47/PD-L1 axis. | Mol Cancer | 2026 | 42436518 | PubTator, text mining | PubMed |
| Kidney failure in a child with Pierpont syndrome: a case report highlight challenges in kidney replacement therapy. | BMC Nephrol | 2026 | 42365304 | PubTator, text mining | PubMed |
| A Novel De Novo Frameshift Variant of TBL1XR1 Leads to Neurodevelopmental Disorders and Treatment Experience. | Int J Dev Neurosci | 2026 | 42281549 | PubTator, text mining | PubMed |
| Dysfunction of a SET3-like complex underlies a family of related neurological disorders. | Nat Commun | 2026 | 42143056 | PubTator, text mining | PubMed |
1 to 10 of 1,924
See all 1,924 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/79718
GET https://conductscience.org/api/genes/v1/79718/patents?page=2